GET DAILY SIGNALSDow Inc. (DOW): Analyst Targets Suggest +13% Upside to $38
Key Takeaways
- The central target of $38 is the arithmetic mean of the three most recent analyst price targets that sit above the current share price: $40 (J.P. Morgan), $39 (Morgan Stanley), and $35 (Wells Fargo).
- The latest verified price for DOW is about $33.62, meaning the stock would need to rise roughly 13% to reach the $38 central target.
- The overall average of all valid analyst targets is materially lower — near $35 — because several firms hold targets between roughly $29 and $33, producing a wide low-to-high range of approximately $29–$41.
- Supporting factors include an improving third quarter, a large cost-savings program, and a modest valuation rebound in a cyclical chemicals sector.
- The biggest risks are weak commodity chemical and polyethylene pricing, repeated downward target revisions through 2026, and a cautious "Hold" consensus.
- For more detail, explore Dow's Major News, Today's Price Move, Forecast, and Earnings pages.
- Readers can also explore Trending AI Robots for automated, data-driven trading ideas.
Analyst Price Targets and Consensus View
Dow Inc. (DOW) is a diversified materials science company — a major producer of polyethylene, packaging and specialty plastics, and performance materials — and one of the largest chemical manufacturers in the United States. It is a stock, not an ETF.
Aggregators show an overall analyst consensus of roughly "Hold," with about 20 analysts covered by S&P Global data and an average one-year price target near $34.76. Because that overall mean is only about 3% above the latest price, it fails the requirement that a meaningful central target be at least 10% higher. The $38 figure is therefore the average of the verified targets above the current price: $40 (J.P. Morgan, Buy), $39 (Morgan Stanley, Hold), and $35 (Wells Fargo, Buy).
The full range is unusually wide — roughly $29 to $41, with some aggregators citing a high near $45. Cautious firms, including RBC Capital ($32), Deutsche Bank ($32), UBS ($30), and Mizuho ($33), cluster below the current price, while Barclays and Bank of America have carried Sell or Underperform ratings. Analysts have repeatedly lowered targets through 2026 on softer commodity pricing, and the gap between bullish and cautious views reflects genuine disagreement about the chemicals cycle. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path Toward the Target
With the stock near $33.62, reaching $38 implies upside of about 13% — a substantial but not extreme move. The stock has already rebounded from its 52-week low near $21 and remains about 20% below its 52-week high near $42.74.
The path toward the target would likely depend on continued improvement in quarterly results and pricing. Dow reported second-quarter 2026 revenue of about $12.09 billion, up 20% year over year, while EPS (earnings per share) of roughly $1.00 missed analyst expectations. A third-quarter report described as a sharp improvement, together with an upgrade from Bank of America to Neutral from Underperform, helped lift shares in late October. Management's "Transform to Outperform" program, targeting about $2 billion in annual savings by 2027–2028, is a central part of the earnings-recovery narrative. From what I see, this self-help story is worth monitoring closely.
What Could Support a Move Toward the Target
- Cost discipline: Self-help savings are running ahead of plan, supporting margin expansion even in a soft pricing environment.
- Revenue recovery: Sales grew 20% year over year in the most recent reported quarter.
- Bullish coverage: J.P. Morgan, Morgan Stanley, and Wells Fargo each hold targets of $35 or higher, above the stock price.
- Valuation: After a deep drawdown, the stock trades well below its 52-week high, leaving room for a re-rating if earnings recover.
- Cyclical leverage: Any improvement in polyethylene and petrochemical pricing or broader economic demand would flow directly to earnings.
What Could Prevent the Target From Being Reached
- Weak chemical pricing: Softer commodity and polyethylene pricing is the most-cited reason for repeated target cuts.
- Earnings volatility: The recent EPS miss highlights the difficulty of forecasting in a cyclical business.
- Cautious consensus: Most firms rate the stock Hold, and several targets sit below the current price.
- Macro sensitivity: Dow's results are tied to global industrial demand, consumer spending, and energy input costs.
- Valuation compression: Analysts have repeatedly assumed lower future P/E (price-to-earnings) multiples when cutting targets.
Technical Levels and Market Structure
The 52-week high near $42.74 is the most durable resistance level above the current price, with the $40 round-number level acting as an intermediate hurdle on the way to the $38 target. The psychological $30 level and the cluster of cautious analyst targets between roughly $29 and $32 define a key support zone. The stock's rebound from its 52-week low near $21 leaves a wide trading range, and a decisive move back above $35 would be an early signal of strengthening momentum toward the analyst-derived $38 objective.
Time Horizon and What Investors Should Monitor
Analyst price targets generally reflect a roughly 12-month horizon, though individual firms differ in their assumptions. Investors should watch quarterly earnings and guidance, any additional analyst target changes, polyethylene and petrochemical pricing trends, progress on the cost-savings program, and macroeconomic data on industrial activity and consumer demand. Energy prices and interest-rate decisions from the FOMC (Federal Open Market Committee) also affect both Dow's input costs and its valuation.
AI Daily Buy/Sell Signals
In my analysis of names like DOW, I find it useful to layer in systematic signals alongside the fundamental picture.
Using Tickeron Tools for Deeper Research
When evaluating stocks such as DOW, I often rely on Tickeron’s AI Daily Buy/Sell Signals to track real-time shifts. The platform applies artificial intelligence to monitor thousands of securities, delivering Buy, Sell, or Hold signals grounded in technical behavior and market conditions. This gives me a structured way to cross-check analyst views and stay alert to momentum changes without replacing my own due diligence.
Final Assessment
The $38 central target for Dow reflects the average of the three analyst targets currently above the stock price, rather than a broad Street consensus, and implies roughly 13% upside from about $33.62. The strongest supports are an improving third quarter, a sizable cost-reduction program, and bullish views from a few major firms; the principal obstacles are weak commodity chemical pricing, a cautious overall consensus, and repeated target reductions through 2026. The wide spread between high and low targets signals genuine uncertainty about the timing of a cyclical earnings recovery. Whether the stock can reach $38 will likely hinge on sustained pricing improvement and margin execution — factors investors should monitor closely rather than treat the target as a forecast.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
DOW's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for DOW turned positive on October 06, 2026. Looking at past instances where DOW's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on DOW as a result. In 60 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
DOW moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for DOW crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +6.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where DOW advanced for three days, in 174 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 125 of 202 cases where DOW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DOW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
DOW broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. DOW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.531) is normal, around the industry mean (1.167). P/E Ratio (-18.372) is within average values for comparable stocks, (3.030). DOW's Projected Growth (PEG Ratio) (38.891) is very high in comparison to the industry average of (3.769). Dividend Yield (0.042) settles around the average of (0.180) among similar stocks. P/S Ratio (0.524) is also within normal values, averaging (0.578).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DOW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of chemicals and specialty materials
Industry ChemicalsMajorDiversified
Advertisement